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Surgery remains the mainstay of soft tissue sarcoma (STS) treatment and has been the primary treatment for the majority of
patients in Scandinavia during the last 30 years although the use of adjuvant radiotherapy has increased. Patient and treatment
characteristics have been recorded in the Scandinavian Sarcoma Group (SSG) Register since 1987. When the eﬀect of new
radiotherapyguidelinesfrom1998wasevaluated,thereliabilityofsurgicalmarginassessmentsamongdiﬀerentScandinavianinsti-
tutions was investigated. Margins were reevaluated by a panel of sarcoma surgeons, studying pathology and surgical reports from
117 patients, randomly selected among 470 recorded patients treated between 1998–2003. In 80% of cases, the panel agreed with
the original classiﬁcation. Disagreement was most frequent when addressing the distinction between marginal and wide margins.
Considered the element of judgment inherent in all margin assessment, we ﬁnd this reliability acceptable for using the Register for
studies of local control of STS.
1.Introduction
Soft Tissue Sarcomas (STSs) are optimally removed with
a safety margin of healthy tissue encompassing the tumor.
After surgery, the completeness of removal is evaluated by
assessing the quality and thickness of this margin. During
the last decades, the margin has most often been classiﬁed
as intralesional, marginal, wide, or radical/compartmental
referring to Enneking et al. [1].
During the early years (1970s) of the Scandinavian
Sarcoma Group’s (SSG) existence, compartmental excisions
according to Enneking were sometimes attempted. However,
betterreferralpractices,withmorepatientsreferredtotumor
centers before surgery, has often made it possible to avoid the
sacriﬁce of function such operations entail. Routine use of
MRI in planning has enabled safe resection margins inside
compartments [2–4]. The surgical goal is currently a wide
margin with a cuﬀ of healthy tissue surrounding the tumor.
For strictly intramuscular tumors, this margin is often
obtained by myectomy [5].
It is widely accepted that the quality of the surgical
margin is of prime importance for local control [6–8]. To
compare results from diﬀerent series and to evaluate other
treatment modalities for local control, a strict deﬁnition of
the margin assessment procedure is needed.
Diﬀerent routines for margin assessment are described
[5, 8–12]. Most studies report a margin assessed by the
surgeon and validated by the pathologist or jointly assessed
by the two. In recent years, it has also been more common
to report whether the pathologist has found microscopic
tumor tissue at the specimen perimeter, deﬁning a positive
or negative margin [13].
Not all studies detail these procedures. The surgeon may
measure the thickness of the smallest margin of surrounding
tissue on the fresh specimen, omitting areas of smaller
distances where there is fascial coverage. The pathologist2 Sarcoma
may measure the thickness of the cuﬀ macroscopically on
fresh or formalin-ﬁxed specimen using a variable amount
of slices. Finally, the smallest distance without fascial cover
can be measured microscopically as the distance from tumor
tissue to an inked surface. The number of slides necessary for
the pathologists’ conclusion may or may not be stated, even
when detailed margin analyses are done [14].
In Scandinavia, a wide surgical margin without radio-
therapy was formerly considered adequate for treatment of
localized STS. Radiotherapy was applied after surgery with
intralesional or marginal margins. From 1998, adjuvant
radiotherapy was recommended by the SSG for all deep
extramuscular, high-grade sarcomas regardless of surgical
margin or size. In the context of evaluating the eﬃcacy of
this change of policy regarding local recurrence rate [15],
the present study evaluates the validity and reliability of the
original assessment of the surgical margin as recorded in
the Central Register of the SSG. Furthermore, we wanted
to investigate if classiﬁcation of surgical margin at diﬀerent
institutions adhered to SSG guidelines.
2. MaterialsandMethods
Nine university hospitals with a sarcoma unit report to the
Central Register. Compiled between 1986 and 2011, this
Register contains data on 8322 bone and soft tissue sarcoma
patients.Theyallhadtheirﬁnaltreatmentforprimarytumor
at a sarcoma centre in Scandinavia. Detailed guidelines for
reporting the variables exist, and these are discussed among
local unit coordinators on a yearly basis. During the ﬁrst
ﬁve-year period after 1998, 470 patients were treated for a
primary, previously not operated, soft tissue sarcoma of the
extremity or trunk wall (liposarcoma grade I excluded) at
four large Scandinavian institutions. These institutions have
contributed 68% of the total content of the Register.
Of the 470 patients, 117 (25%) were randomly selected
for blinded reassessment of margins by four sarcoma sur-
geons representing the above-mentioned institutions.
The evaluation was based on reports from the operation
and the pathology evaluation. The original margin classiﬁ-
cation as reported to the SSG Central Register was in most
cases based on collaboration between the local surgeon and
the pathologist.
Guidelinesformarginassessmentinthisstudywerethose
sited in “Centralized Registration of Sarcoma Patients in
Scandinavia SSG VII: 2 Modiﬁed 31 March 1995.”
Deﬁnitions. The deﬁnitions of surgical margins are basically
those of the Surgical Staging System (SSS, Enneking et al.
1980) and those given by SSG 1981 in “Adjuvant chemother-
apy in soft tissue sarcoma” (Bertil Stener).
Intralesional: intracapsular, subtotal, piecemeal re-
moval.
Marginal: the dissection is close to the tumor in one
or more places, perhaps all around (shelling out,
excisional biopsy). If during an operation, that is
intended to be a wide excision, the tumor is unex-
pectedly exposed in one single place, or if histological
examination reveals that the margin is marginal in
one single place, the excision should be described
as marginal, irrespective of how much healthy tissue
is included elsewhere.
Wide (without fascial containment of the surgical
specimen): the tumor is removed en bloc completely
surrounded by a safety margin of healthy tissue. The
tumor is not completely surrounded by an unbroken
ﬁbrous boundary. A wide margin for a subcutaneous
sarcoma requires inclusion of the deep fascia beneath
the tumor. For a tumor located between muscles,
the muscles around the tumor are included in the
surgical specimen.
Myectomy (wide with fascial containment of the
surgical specimen): the muscle in which the tumor
is located is removed unopened along with its ﬁbrous
boundary (sometimes bone).
Compartmental: the tumor-involved compartment
(deﬁned according to SSS) is removed en bloc.
In the SSG, the margin should be assessed on the patho-
logical specimen after ﬁxation in formalin and ink-dying
of the surface. The specimen is sliced at maximum 1cm
increments and gross-sections or partial gross-sections are
made from areas of closest margin at the surgeon’s guidance.
The pathology report must also include an evaluation of the
quality of the margin and the tumors growth pattern at the
periphery.
The SSG originally deﬁned “the cuﬀ of healthy tissue” at
around 5cm. As in other parts of the world there has been
a gradual change to acceptance of a smaller cuﬀ. Today, the
SSG deﬁnes the wide margin as a cuﬀ of at least 10mm
nonfascial tissue surrounding the tumour.
The panel was blinded for the original assessment
when independently scrutinizing the surgical and pathology
reports. The surgeons did not evaluate margins from their
own institution.
During a second round of assessments, all four surgeons
convened, and the 25 cases where they disagreed with each
other during the independent round were discussed before a
ﬁnal agreement was reached. The originally recorded margin
was then disclosed.
3. Results
Among the 117 patients, originally recorded margins were 8
intralesional, 43 marginal, and 66 wide.
First Round. In 71% of cases, all three reviewers agreed
and in 8% all three reviewers disagreed with the original
classiﬁcation. In 19/117 (16%), one reviewer disagreed, and
in 6/117 (5%), two reviewers disagreed. When all reviewers
disagreed, disagreement was most frequent when addressing
the distinction between marginal and wide margins. Reclas-
siﬁcation from marginal to wide and from wide to marginal
was equally favored.Sarcoma 3
Second Round. In 17 of 25 cases of disagreement among the
surgeons, one reviewer changed opinion after listening to the
arguments of the other three. In 5/25 cases, two reviewers
changed opinion, and in 3/25, there was no change of a
diﬀering opinion.
The opinion changes were not necessarily in favor of the
original classiﬁcation.
The ﬁnal result was agreement with the original assess-
ment in 80% of cases (Figure 1). After discussing the cases,
more reviewers favored a change from marginal to wide
margin than vice versa (Figure 2).
After a median followup of 7, 8 years, 11 patients expe-
rienced a local recurrence of which the distribution among
assessment groups is given in Table 1.
4. Discussion
We present two diﬀerent ways of margin reviewing. An
independent approach and a discussion among reviewers. It
is not obvious which is the most reliable, and we think both
methods convey valuable information.
Margin assessment years after the original recording is
not the same as real-time evaluation, even if guidelines are
the same. The judgment by the operating surgeon concern-
ing the completeness of resection has elements of quality
beyond his written report. This may be illustrated by studies
of breast cancer surgeons’ ability to determine the margin
based on examination of the gross specimen [16–18].
When many hospitals are classifying margins, hetero-
geneity might be more pronounced than for single institu-
tion materials. Among hospitals participating in this study,
one institution systematically emphasized the pathologist’s
measurements of distances on formalin-ﬁxed specimens to
diﬀerentiate between marginal and wide margins. Conse-
quently, this institution reported 15% less cases of wide
marginthantheothers.Mostcaseswherethepanelsuggested
a change from marginal to wide margin represented patients
from this institution. If the reassessment had been carried
out without this institution, the panel would have disagreed
with the original margin classiﬁcation in only 7% of cases.
This illustrates the need for a large sample size when multi-
center margins are evaluated.
The need for carefully deﬁning both study population
and how margins are classiﬁed is illustrated by local recur-
rence rates following various margins. Enneking et al. [19]
originally reported a 50% local recurrence rate after a
marginal margin, 25% after a wide, and 4% after radical
resection. Modern series typically have 90% local control
after wide margins or after marginal margins with additional
radiotherapy [15].
None of the intralesional margins in the present study
represented cases with gross tumor left. They were all
primarily treated at a sarcoma center, and an area of positive
margin was typically present only in a small part of the spec-
imen. The distinction between intralesional and marginal
margins may, therefore, be of limited prognostic value in
this material. From this point of view and without the
institution emphasizing the pathologists measurements,
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Figure 1: Final agreement among three reviewers with original
margin classiﬁcation. 117 randomly selected cases from four large
Scandinavian sarcoma centers, treatment 1998–2003.
0
1
2
3
4
5
6
7
8
1/22
7/22
5/22
9/22
Marginal to
intralesional
Intralesional
 to marginal
Wide to 
marginal/
intralesional
Marginal to 
 wide
(%)
Figure 2: A fraction of patients where all reviewers agreed on
ad i ﬀerent margin than originally reported to the SSG Register
relative to the total amount of cases reviewed (n = 117).
the fraction of disagreeing margin assessments of prognostic
signiﬁcance could be regarded to be less than 4%.
Among the cases that eventually had a local recurrence,
none had all reviewers agreeing on a diﬀerent margin than
the original one.
Studies of interobserver variability in assessment of sur-
gical margin, attempting a diﬀerentiation between marginal
and wide margins, are not published. When assessing only
the likelihood of residual tumor at the resection margin,
two reviewers disagreed on only 1/62 patients [20]. When
addressing only positive or negative margins after radical
prostatectomy, a very low interobserver variability among 10
pathologists was reported [21].
In a resent SSG series of treatment results in STS, the
surgical margins were wide or better in 76% of subcutaneous
lesions and in 58% of deep-seated lesions [15]. Amputation
rate was 7% and had been declining. The rate of wide
margins obtained was lower than reported in other series
[9, 22, 23]. The local recurrence risk was, however, similar.
ThismightimplythattheScandinaviandeﬁnitionofmargins
may be somewhat more rigorous.4 Sarcoma
Table 1: 11 Local recurrences and margin assessments.
Number of recurrences
relative to type of margin Original margin assessment Radiation Reviewer assessments
4/66 wide 1/4 All reviewers agreed on wide
2/43 marginal 0 All reviewers agreed on marginal
2 marginal 0 Two reviewers intralesional, one marginal
1/8 intralesional 1/1 All reviewers agreed on intralesional
1 marginal 1/1 Two reviewers wide, one marginal
1 wide 0 Two reviewers wide, one marginal
Since the ﬁrst SSG protocol for STS adjuvant treatment
in 1981, the Surgical Staging System (SSS) has been in use
when recording margins in Scandinavia [1]. These principles
were also adopted when the SSG Central Register was
establishedin1987.TheSSSrecommendsthe“cuﬀofhealthy
tissue,” required for a wide margin, to be as extensive as “is
practically possible.” No ﬁxed measurements were originally
given, but 3cm of healthy tissue was required around the
biopsy tract, and 5cm surrounding the tumor on fresh,
unﬁxed specimen was often advocated later. The concept of
Enneking’s reactive zone omits the need for any measure-
ment.Theproblemisthatthereactivezoneispoorlydeﬁned,
often not visible on histological slides, and many STSs do not
have a reactive zone.
In 2006, positive/negative margins were introduced for
the SSG Central Register. The intralesional margin is catego-
rized into two types: macroscopic tumor tissue left behind
or not. A marginal margin is recorded when the plane of
excisionpassesoutsidethetumor,butinanyparttoocloseto
thetumortomeritawidemargin.Inotherterminologies,the
intralesional margin (both types) corresponds to a positive
margin whereas the marginal margin corresponds to a
negative margin.
A wide margin is recorded when the excised tumor is
surrounded all around by a cuﬀ of healthy tissue or unin-
volved fascia. The margin obtained by myectomy is regarded
as a subtype of the wide margin and has been applied
for strictly intramuscular lesions (not subjected to open
biopsy) when the involved muscle, from origin to insertion,
is completely removed.
The necessary thickness of the cuﬀ to merit a wide
margin has been discussed during the years. In the latest
soft tissue sarcoma protocol (SSG XX) active from 2007,
ac u ﬀ thicker than 10mm in a formalin-ﬁxed specimen is
consideredadequateforawidemargintoberecorded.Future
studies may utilize improved methodology when evaluating
the adequacy of planning treatment and reporting proce-
dures, for the resection of soft tissue sarcoma [24].
5. Conclusion
For multicenter studies of prognostic signiﬁcance of sur-
gical margins, written guidelines for margin assessment
are important. The procedure of margin assessment in
Scandinavia can be considered valid for measuring the real
distance between the tumor surface and the resection
margin. It is also reasonably reliable as there is a high level
of agreement among sarcoma surgeons evaluating the pro-
cedure retrospectively. Considered the element of judgment
inherent in all margin assessment, we ﬁnd this validity and
reliability acceptable for using the Scandinavian Sarcoma
Group Register for studies of local control.
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